Literature DB >> 8554449

Expression of human Pit-1 product in the human pituitary and pituitary adenomas. Immunohistochemical studies using an antibody against synthetic human Pit-1 product.

N Sanno1, A Teramoto, A Matsuno, R Y Osamura.   

Abstract

OBJECTIVE: Pit-1, a member of a family of the POU-domain DNA binding factors, has been known as a pituitary-specific transcriptional factor that regulates functional differentiation toward somatotrophs, lactotrophs, and thyrotrophs in the rodent pituitary gland. The aim of this study is to elucidate the role of human Pit-1 (hPit-1) protein in the differentiation of human pituitary adenomas, using immunohistochemistry.
DESIGN: Anti-human Pit-1 polyclonal antibody against synthetic peptide was applied to perform the avidin-biotinperoxidase complex method on paraffin sections of 75 surgically obtained pituitary adenomas and 12 nontumorous human pituitaries obtained at autopsy.
RESULTS: In normal human pituitary glands, many cells were positive for hPit-1 product in the nuclei of somatotrophs, lactotrophs, and somatomammotrophs. Among 75 pituitary adenomas, hPit-1 product was expressed in 55 adenomas (73.3%). All (100%) of the growth hormone-positive and thyrotroph cell adenomas were positive for hPit-1 product. Unexpectedly, expression of hPit-1 was found in a limited number of adrenocorticotropic hormone-producing adenomas and clinically nonfunctioning adenomas, including gonadotroph cell adenomas, although localization was found only in occasional cells.
CONCLUSIONS: The invariable expression of hPit-1 protein in growth hormone-positive adenomas and thyroid-stimulating hormone-positive adenomas may suggest the role of Pit-1 protein in specific differentiation of the adenoma cells. The expression of hPit-1 in various other types of adenomas may indicate the involvement of other unidentified transcription factors or specific mediators that have roles in these differentiations. Our observation may provide some insight into the origin of cell types of some clinically nonfunctional adenomas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8554449

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  8 in total

Review 1.  Pit-1 positive alpha-subunit positive nonfunctioning human pituitary adenomas: a dedifferentiated GH cell lineage?

Authors:  R Y Osamura; S Tahara; K Komatsubara; Y Itoh; H Kajiwara; R Kurotani; N Sanno; A Teramoto
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

2.  Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice.

Authors:  J McKee Alderman; Kevin Flurkey; Natasha L Brooks; Sneha B Naik; Jonathan M Gutierrez; Urmila Srinivas; Kristen B Ziara; Linhong Jing; Gunnar Boysen; Rod Bronson; Simon Klebanov; Xian Chen; James A Swenberg; Mats Stridsberg; Carol E Parker; David E Harrison; Terry P Combs
Journal:  Exp Gerontol       Date:  2008-06-07       Impact factor: 4.032

3.  Expression of Ptx1 in the adult rat pituitary glands and pituitary cell lines: hormone-secreting cells and folliculo-stellate cells.

Authors:  R Kurotani; S Tahara; N Sanno; A Teramoto; P L Mellon; K Inoue; S Yoshimura; R Y Osamura
Journal:  Cell Tissue Res       Date:  1999-10       Impact factor: 5.249

4.  Immunonegative "null cell" adenomas and gonadotropin (Gn) subunit (SUs) immunopositive adenomas share frequent expression of multiple transcription factors.

Authors:  Yudo Ishii; Masanori Suzuki; Susumu Takekoshi; Noboru Egashira; Michio Yamazaki; Shunsuke Miyai; Naoko Sanno; Akira Teramoto; Robert Yoshiyuki Osamura
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

5.  Reverse transcription polymerase chain reaction analysis of pituitary hormone, Pit-1 and steroidogenic factor-1 messenger RNA expression in pituitary tumors.

Authors:  M T McDermott; B R Haugen; D F Gordon; W M Wood; N S Brown; C A Bauer; M J Garrity; B K Kleinschmidt-DeMasters; K O Lillehei; M H Samuels; T M Bright; E C Ridgway
Journal:  Pituitary       Date:  1999-11       Impact factor: 4.107

6.  Double adenoma of the pituitary: a somatotroph adenoma colliding with a gonadotroph adenoma.

Authors:  L V Syro; E Horvath; K Kovacs
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

7.  Deregulation of the Pit-1 transcription factor in human breast cancer cells promotes tumor growth and metastasis.

Authors:  Isabel Ben-Batalla; Samuel Seoane; Tomas Garcia-Caballero; Rosalia Gallego; Manuel Macia; Luis O Gonzalez; Francisco Vizoso; Roman Perez-Fernandez
Journal:  J Clin Invest       Date:  2010-11-08       Impact factor: 14.808

8.  Expression of Pit-1 and growth hormone-releasing hormone receptor mRNA in human pituitary adenomas: difference among functioning, silent, and other nonfunctioning adenomas.

Authors:  Ikuo Kobayashi; Hidehiro Oka; Heiji Naritaka; Yuichi Sato; Kiyotaka Fujii; Toru Kameya
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.